Processes and Practices Applicable to Bioresearch Monitoring Inspections

Processes and Practices Applicable to Bioresearch Monitoring Inspections; Guidance for Industry; Availability

This document is not a NEPA document. It is an FDA Federal Register notice announcing the availability of a final guidance for industry entitled 'Processes and Practices Applicable to Bioresearch Monitoring Inspections,' issued to comply with the Food and Drug Omnibus Reform Act of 2022. It describes FDA's Bioresearch Monitoring inspection program practices, communication standards, and record requirements. No environmental review, alternatives analysis, or impact assessment is present. This record cannot be meaningfully populated as a NEPA metadata entry.

Processes and Practices Applicable to Bioresearch Monitoring Inspections; Draft Guidance for Industry; Availability

This is not a NEPA document. The Federal Register notice announces the availability of an FDA draft guidance entitled 'Processes and Practices Applicable to Bioresearch Monitoring Inspections,' issued under the Food and Drug Omnibus Reform Act of 2022. It describes FDA's Bioresearch Monitoring inspection program, covering records requirements, communication practices, and inspection conduct. No environmental review, geographic project area, alternatives analysis, or NEPA process is involved. A structured NEPA metadata record cannot be meaningfully populated from this document.